Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C

Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C

Aim. Evaluate efficacy and safety of a combination of direct - acting antivirals narlaprevir/ritonavir with daclatasvir in patients with viral hepatitis C. Materials and methods. The study enrolled adult patients with HCV genotype 1b infection without demonstrated NS5A resistance - associated substi...

Full description

Bibliographic Details
Main Authors: E A Klimova, E Z Burnevich, V P Chulanov, D A Gusev, O O Znoyko, S N Batskikh, S N Kizlo, N A Mamonova, E P Tarkhova, E N Krasavina, M Yu Samsonov, N D Yushchuk
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2019-08-01
Series:Терапевтический архив
Subjects:
narlaprevir
ritonavir
daclatasvir
chronic hepatitis c
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/33621/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/33621/pdf

Similar Items